EDN3 and breast carcinoma: The results of our ET-3 stimulated invasion assays reveal an inhibitory role of ET3-stimulated EDNRB on breast cancer invasion (Fig. 4), in contrast to the pro-invasive role of ET1-stimulated EDNRB reported by Hagemann et.